DIN 02551799 — AYVAKYT 200 MG
AYVAKYT is a tablet of Avapritinib marketed by BLUEPRINT MEDICINES CORPORATION. The full Avapritinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02551799
- Brand name
- AYVAKYT
- Active ingredient
- Avapritinib
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BLUEPRINT MEDICINES CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Tyrosine kinase inhibitor (KIT/PDGFRA inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Avapritinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02551780 | AYVAKYT | 100 MG | TABLET | BLUEPRINT MEDICINES CORPORATION | MARKETED |
| 02551764 | AYVAKYT | 25 MG | TABLET | BLUEPRINT MEDICINES CORPORATION | MARKETED |
| 02551772 | AYVAKYT | 50 MG | TABLET | BLUEPRINT MEDICINES CORPORATION | MARKETED |